drugset / Trial / NCT03187002
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion
RandomizedParallel-groupTriple-blindTreatment
Summary
High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.
Timeline
- Start
- 2018-01-18
- Primary completion
- 2019-10-31
- Completion
- 2019-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | — | Intravenous |
| Comparator | Midazolam | Small molecule | — | Intravenous |
Indications
No indication recorded.